Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction

Sim Namkoong1,2, Minsu Jang1, Jeong In Lee2

  • 1Division of Biological Science and Technology, Yonsei University, Wonju, Republic of Korea.

Insights

The tumor suppressor p53 regulates ITM2A, which then inhibits p53 activity, forming a feedback loop. Reduced ITM2A levels correlate with poor survival in cancers with faulty p53.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • The tumor suppressor p53 is critical for preventing cancer.
  • p53 dysfunction is common in many cancers.
  • A novel interaction between p53 and ITM2A was investigated.

Purpose of the Study:

  • To identify and characterize the regulatory relationship between p53 and ITM2A.
  • To explore the functional consequences of this interaction in cancer.

Main Methods:

  • Western blotting and quantitative PCR to assess protein and mRNA levels.
  • Immunoprecipitation to confirm physical interaction.
  • Phosphorylation site analysis and subcellular localization studies.
  • Reporter assays to measure transcriptional activity.

Main Results:

  • p53 upregulates ITM2A expression, creating a negative feedback loop.
  • ITM2A expression is reduced in multiple tumor types, especially with mutant p53.
  • Low ITM2A correlates with decreased patient survival.
  • ITM2A modulates p53 phosphorylation, promotes cytoplasmic localization, and suppresses p53 transcriptional activity.
  • ITM2A depletion enhances p53 nuclear accumulation and activity.

Conclusions:

  • A novel p53-ITM2A autoregulatory circuit was discovered.
  • ITM2A acts as a negative regulator of p53.
  • ITM2A may serve as a prognostic marker and therapeutic target in cancers with p53 alterations.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...